Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Capital Expenditures (2016 - 2025)

Balchem (BCPC) has disclosed Capital Expenditures for 16 consecutive years, with $16.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 27.42% to $16.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.5 million, a 21.95% increase, with the full-year FY2025 number at $43.5 million, up 21.95% from a year prior.
  • Capital Expenditures was $16.2 million for Q4 2025 at Balchem, up from $14.9 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $16.2 million in Q4 2025 to a low of $5.6 million in Q1 2025.
  • A 5-year average of $10.2 million and a median of $9.4 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 73.72% in 2022, then tumbled 44.66% in 2023.
  • Balchem's Capital Expenditures stood at $15.0 million in 2021, then fell by 5.48% to $14.2 million in 2022, then decreased by 17.22% to $11.7 million in 2023, then increased by 8.62% to $12.7 million in 2024, then rose by 27.42% to $16.2 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Capital Expenditures are $16.2 million (Q4 2025), $14.9 million (Q3 2025), and $6.8 million (Q2 2025).